Compositions for treatment of diabetic complications

Details Compositions for treatment of diabetic complications Compositions for treatment of diabetic complications

A - Human Necessities

61

K

A61K 31/375 (2006.01) A61K 31/20 (2006.01) A61K 31/415 (2006.01) A61K 31/425 (2006.01) A61K 31/50 (2006.01) A61K 31/54 (2006.01)

Patent

CA 2152321

Use of 6-desaturated n-6 fatty acids, especially gammalinolenic acid (GLA), dihomogammalinolenic acid (DGLA) or arachidonic acid (AA), together with a pharmaceutically acceptable material reducing intracellular levels of sorbitol in the body, particularly an aldose reductase inhibitor, in the treatment of (including prophylactic treatment), and in the preparation of medicaments for the treatment of (including prophylactic treatment), the long-term complications of diabetes mellitus. Pharmaceutical compositions of said materials. The ascorbate esters of 6-desaturated n-6 fatty acids (other than GLA or DGLA) per se.

Affiliated with

Also associated with

Rating

Compositions for treatment of diabetic complications does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions for treatment of diabetic complications, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for treatment of diabetic complications will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1879309